Biotec Pharmacon aims to increase knowledge of the company through precise and confident communication with shareholders, analysts and investors.
Biotec Pharmacon is committed to providing consistent, open, timely, equal, and relevant information to stakeholders, including the stock market.
Biotec Pharmacon normally holds open investor presentations in connection with the submission of quarterly results. Recorded webcasts from the presentations are available for at least 12 months.
News, performance reports and presentations are posted on the company’s website biotec.no. Press releases are distributed as well through CisionWire.